Cargando…
Myostatin in the Arterial Wall of Patients with End-Stage Renal Disease
Aim: Myostatin (Mstn) has been described as a trigger for the progression of atherosclerosis. In this study, we evaluated the role of Mstn in arterial remodeling in patients with end-stage renal disease (ESRD). Methods: Vascular specimens were collected from 16 ESRD patients (56.4 ± 7.9 years) under...
Autores principales: | Esposito, Pasquale, Verzola, Daniela, La Porta, Edoardo, Milanesi, Samantha, Grignano, Maria Antonietta, Avella, Alessandro, Gregorini, Marilena, Abelli, Massimo, Ticozzelli, Elena, Rampino, Teresa, Garibotto, Giacomo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Atherosclerosis Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585912/ https://www.ncbi.nlm.nih.gov/pubmed/32173683 http://dx.doi.org/10.5551/jat.51144 |
Ejemplares similares
-
Modulation of Myostatin/Hepatocyte Growth Factor Balance by Different Hemodialysis Modalities
por: Esposito, Pasquale, et al.
Publicado: (2017) -
Significance of serum Myostatin in hemodialysis patients
por: Esposito, Pasquale, et al.
Publicado: (2019) -
Myostatin/Activin-A Signaling in the Vessel Wall and Vascular Calcification
por: Esposito, Pasquale, et al.
Publicado: (2021) -
Activin/myostatin receptor signaling and vascular calcifications in chronic kidney disease: A “liaison dangereuse”?
por: Garibotto, Giacomo, et al.
Publicado: (2019) -
Enhanced myostatin expression and signalling promote tubulointerstitial inflammation in diabetic nephropathy
por: Verzola, Daniela, et al.
Publicado: (2020)